BEIJING, Aug. 8 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB) ("Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals in the People's Republic of China, today announced that it has retained CCG Investor Relations to assist in the design and execution of its investor relations program.
Yongye is engaged in the development, distribution and sales of fulvic acid based liquid and powder nutrients for plants and animals. Yongye currently markets and sells its nutrients for plants in ten provinces and its nutrients for animals in four provinces. The Company sold 106,000 units (approximately 1,100 metric tons) of nutrients for plants and 13,800 units (approximately 4 metric tons) of nutrients for animals in 2007. Nutrients for plants contributed 87%, and nutrients for animals contributed 13%, of the Company's $13.1 million total revenue in 2007. In the first quarter of 2008, the Company sold 75,500 units of nutrients for plants (approximately 756 metric tons) and 47,035 units of nutrients for animals (approximately 14 metric tons), which contributed 83% and 17%, respectively, of the Company's $9.5 million total revenue.
"Our proprietary technology for fulvic acid extraction produces some of
the purest and most bioactive fulvic acid in China. We combine this fulvic
acid base with other ingredients using our proprietary formulae to create
some of the most effective nutrients for plants and animals available in
China. We plan to increase distribution and sales within our existing
markets in the third and fourth quarters of 2008, and help our customers
consistently achieve reliable results through use of our high quality
products," said Mr. Zishen Wu, Chairman and CEO of Yongye Biotechnology
International, Inc. "Along with expanding our operations, we look forward
to working with CCG to improve our visibility in the investment community
and with th
|SOURCE Yongye Biotechnology International, Inc.|
Copyright©2008 PR Newswire.
All rights reserved